An act relating to health insurance coverage for biomarker testing

This bill requires health insurance plans in Vermont to cover biomarker testing when the test has clinical utility, meaning it helps guide treatment decisions for a patient's condition. It directly affects health insurers, Medicaid programs, and patients who need testing to diagnose, treat, or monitor diseases. The law specifies that coverage applies when tests are supported by FDA approvals, Medicare coverage decisions, or nationally recognized clinical guidelines, and it aims to minimize disruptions in care by reducing the need for multiple biopsies. The changes will take effect on January 1, 2025, for plans issued on or after that date, with full implementation no later than January 1, 2026.